Telness Tech Becomes Valdyr, Making Seamless OS the AI-Native Execution Layer for Telecom Operators
15.9.2026 14:30:00 CEST | Business Wire | Press Release
Valdyr positions Seamless OS as the AI-native execution layer for telecom operators: the layer on which commercial decisions are carried out, rather than a system of record that reports on them. Offers, subscriptions, billing, provisioning, customer journeys and integrations run in one place, telecom processes are built as automated workflows instead of custom development, and AI is applied to commercial and customer-facing operations inside the platform rather than sold as a separate product.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260915818094/en/
Telness Tech is rebranding and becoming Valdyr
The platform supports operators across the United States, Europe and beyond. Recent additions include Telia, the Nordic incumbent operator, and Truecaller, the caller-identification company.
"We ran an operator on the same legacy systems everyone else runs on, and developed our way out of them, creating Seamless OS," said Martina Klingvall, Founder and CEO of Valdyr. "Making an operator AI-native is not a feature you buy, it is an operating model. Our ambition is to move live operators onto that model without a three-year program, so that changing the business gets as easy as launching one."
Migration is treated as part of the product rather than a consulting engagement. Offers, users, subscriptions, billing and integrations move system by system, with readiness checks and a visible cutover state, allowing operators to modernize in stages while customers, data and brand remain in place.
"Telness Tech was named for where we came from. Valdyr is named for what remains once the old stack goes," said Sebastian Stecki, CMO of Valdyr. "As we increasingly work with larger operators, individual launches are not the largest hurdle. They run large businesses on legacy systems and processes, turning every commercial change into a complex series of technical projects, and AI-native execution is what finally removes that cost."
The Valdyr brand takes effect immediately across the company's website, product surfaces and communications. Seamless OS retains its name, roadmap and release cadence, and existing agreements, contacts and integrations are unaffected.
Further information is available at www.valdyr.tech.
About Valdyr
Valdyr, previously Telness Tech, is an international technology company and the developer of Seamless OS, the AI-native execution layer that enables telecom operators to run and evolve mobile services through automation, workflows and AI rather than development projects. Originally developed within the Swedish operator Telness, one of Europe's highest-rated mobile operators run at the leanest setups in the industry, Seamless OS supports operators across the United States, Europe and beyond. Valdyr was founded in 2022 and is headquartered in Stockholm, Sweden.
Multimedia
Graphic available on request: Telness Tech has changed its name to Valdyr. The company's platform, Seamless OS, keeps its name and roadmap. (Graphic: Valdyr)
View source version on businesswire.com: https://www.businesswire.com/news/home/20260915818094/en/
Contacts
Sebastian Stecki
CMO, Valdyr
+46 73 958 40 86
sebastian@valdyr.tech
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo ® ) in Patients With Mycosis Fungoides and Sézary Syndrome12.10.2026 08:00:00 CEST | Press Release
Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides (MF) and Sézary Syndrome (SS). Presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting 2026 in Berlin, Germany, the findings represent one of the largest real-world evaluations of mogamulizumab in Germany and add to the growing body of evidence supporting its use in routine clinical practice.1-3 Conducted as a company-sponsored, multicentric, non-interventional, combined retro-prospective real-world study across 18 centres throughout Germany, MINT brought together cutaneous T‑cell lymphoma (CTCL) specialists to evaluate treatment outcomes with mogamulizumab in a real-world setting, with time-to-next-treatment (TTNT) as the study’s primary endpoint.1 The study captured a broad and heterog
Megaport Expands Global Automated Infrastructure Platform Into Portugal12.10.2026 08:00:00 CEST | Press Release
Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of its services in Portugal, expanding its European footprint and enabling enterprises and service providers in the region to connect instantly to the world’s leading cloud, network, and data center providers. With new on-ramps in Lisbon, customers in Portugal can now access Megaport’s automated infrastructure platform as well as more than 1,200 enabled data centers worldwide. This launch gives enterprises, MSPs, and carriers private, high-performance compute, network, and storage, as well as on-demand regional interconnection with scalable bandwidth. With Portugal’s data center market projected to reach US$3.09 billion by 2030 as well as Lisbon’s proximity to major submarine cable landings, the strengthening global connectivity hub is a natural next step for Megaport. “Portugal’s digital economy is rapidly growing, and infrastructure is at the heart of that transfor
Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 18:09:00 CEST | Press Release
Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,
Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 12:30:00 CEST | Press Release
As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged
Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom